论文部分内容阅读
目的:分析脑卒中并发肺炎患者应用抗菌药物治疗的疗效及预后。方法:选取2014年1月—2015年2月期间在安吉县中医医院进行治疗的120例脑卒中并发肺炎患者进行研究分析。其中在西医常规治疗基础上加用抗菌药物进行治疗的60例患者为观察组,在西医的常规治疗基础上加用痰热清进行治疗的60例患者为对照组。结束治疗后,对两组患者临床疗效、临床症状体征消失时间、病原菌清除情况及不良反应发生情况进行对比分析。结果:经治疗后,观察组患者的总有效率(95.00%)明显高于对照组患者(75.00%),二者间的差异有统计学意义(P<0.05);对两组患者治疗后临床症状体征消失时间情况进行比较,观察组的患者的发热、咯黄脓痰、肺部哮鸣音病症的消失时间及末梢血象恢复时间、住院时间明显少于对照组,二者间的差异具有统计学意义(P<0.05);对比两组患者治疗后病原菌清除情况,观察组分离出的病原菌76株,清除的病原菌有75株;对照组分离出的病原菌有78株,清除的病原菌有72株;对比两组患者不良反应发生情况,治疗组患者不良反应的发生率明显低于对照组,二者间的差异有统计学意义(P<0.05)。结论:抗菌药物在对脑卒中并发肺炎患者进行治疗时与痰热清治疗相比较,疗效更为确切、且治愈率高、临床症状体征消失时间快、并发症发生率低。
Objective: To analyze the curative effect and prognosis of anti-bacterial drugs in patients with stroke and pneumonia. Methods: A total of 120 patients with stroke complicated with pneumonia were selected from January 2014 to February 2015 in Anji County Chinese Medicine Hospital. Among them, 60 patients treated with antimicrobial agents on the basis of conventional treatment of Western medicine were observed group, and 60 patients treated with Tanreqing on the basis of conventional treatment of Western medicine were control group. After the end of treatment, the two groups of patients clinical efficacy, clinical symptoms and signs disappeared time, clearance of pathogens and adverse reactions were compared. Results: After treatment, the total effective rate (95.00%) in the observation group was significantly higher than that in the control group (75.00%), the difference between the two groups was statistically significant (P <0.05) Symptoms and signs of disappearance of time were compared with the observation group patients with fever, slightly purulent sputum, pulmonary wheeze symptoms disappear time and peripheral blood recovery time, hospitalization was significantly less than the control group, the difference between the two statistics (P <0.05). Comparing the clearance of pathogenic bacteria after treatment in both groups, 76 strains of pathogenic bacteria isolated from the observation group and 75 strains of pathogenic bacteria were eliminated from the control group, 78 strains of pathogens isolated from the control group and 72 strains of pathogenic bacteria from the control group, The incidence of adverse reactions in the treatment group was significantly lower than that in the control group. There was significant difference between the two groups (P <0.05). Conclusion: Compared with Tanreqing treatment, the antibacterials have a more accurate curative effect in treating patients with stroke complicated with pneumonia, and the cure rate is high, the clinical symptoms and signs disappear quickly, and the complication rate is low.